A vaccine for kids under 5 could finally be near

At long last, Moderna said Wednesday that it plans to ask US regulators to approve two shots of its vaccine for children aged 6 months to 5 years. But at one-quarter of the strength of the adult shots, the regimen will offer children only moderate protection from infection, my colleague Ryan Cross reported. 

Still, the move could mean that relief is near for families with young children who have been anticipating the doses for months. Parents are waiting to hear about the future of the Pfizer vaccine, too. That regimen for kids under 5 is delayed until at least April, while the Food and Drug Administration reviews data for a potential third dose. 

If you’re a parent to an infant or toddler, the Globe wants to hear your thoughts about the Moderna announcement.